Breaking News
Close
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free

Hikma Pharmaceuticals PLC (HIK)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,634.50 -19.50    -1.18%
10:30:04 - Real-time Data. Currency in GBP ( Disclaimer )
  • Volume: 38,121
  • Bid/Ask: 1,635.00 / 1,636.50
  • Day's Range: 1,633.00 - 1,667.50
Type:  Equity
Market:  United Kingdom
ISIN:  GB00B0LCW083 
SEDOL:  B0LCW08
Hikma Pharma 1,634.50 -19.50 -1.18%
RankUsernameTotalClosedWinningWin %Chg. %
1kaz kaz99888.89+45.09%
2Salvis Lapins333100+39.72%
3Geoff Laidlaw99555.56+36.89%
4Gerard Ducker44375+19.75%
5Callum Stephen111100+18.82%
6Shadi Khalil111100+15.45%
7Anita Vacca131313100+13.47%
8Ahmed Mahomed77342.86+11.67%
9Waseem Durrah1010440+9%
10Steve Oliphant222100+8.92%
11Peter Saunders111100+8.63%
12Richard Smithers111100+8.37%
13Mohammed Alsous111100+6.66%
14Ameet Shah111100+6.42%
15Simon Miller111100+6.3%
16Edward Hammock111100+6.11%
17Raed Dado33266.67+5.01%
18john woolfitt111100+3.78%
19ziya yılmaz55480+3.58%
20Adam Cooper111100+3.45%
21Edrees Hathurani111100+2.75%
22Iñaki Corcoy1000+1.88%
23Andrew Davis111100+1.59%
24joe sahyoun111100+0.17%
25Елена Иванова111100+0.16%
26Martin Riess1000+0.05%
27Mohammad Dado11000%
28vipul popli1100-0.1%
29Ali Armoush1100-0.27%
30Sharad Patel1100-1.28%
31john silk22150-2.74%
32Joe Bucks1100-2.82%
33Mohamed Salaymeh76466.67-2.98%
34Ahmad Dado1100-3%
35Nayef Stetieh22150-3.33%
36Max Young1100-4.56%
37fokrul islam1100-6.08%
38Hussein Alwash33133.33-7.13%
39Jason Taylor1100-8.8%
40Pradip Patel1100-8.91%
41Peter Holmes1100-9.24%
42Nyunt Tin1100-10.56%
43john woolfitt1100-10.83%
44Mistral Magic1100-22.06%
45Hani Khader33133.33-27.67%
46Amro Hammad22150-32.58%
47Fletcher Stewart1100-32.82%
48Mohamad Bassam1100-34.25%
49Pawnjeet Matharu1100-34.34%
50David Connolly1100-36.04%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

HIK Comments

Write your thoughts about Hikma Pharmaceuticals PLC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Adeel Khan
Adeel Khan Oct 09, 2020 16:54
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Touch 27 today
Adeel Khan
Adeel Khan Sep 12, 2020 14:06
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Next results will be super. Wait for it to hit £32 before end of this year
Jonny Tr
Jonny Tr Jun 17, 2020 15:58
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Aim listed Dark Matter Ltd, has more potential
Adeel Khan
Adeel Khan May 11, 2020 17:01
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This will go up & up
Steve Oliphant
Steve Oliphant Dec 04, 2019 9:30
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Not as stated here (March 11)
Steve Oliphant
Steve Oliphant Dec 04, 2019 9:29
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hikma will announce their results for the year ended 31 December 2019 on 27 February 2020
Geoff Laidlaw
Geoff Laidlaw Jun 27, 2018 11:52
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any hint of progress on Advair will send this stock much higher still !
Geoff Laidlaw
Geoff Laidlaw May 18, 2018 21:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Underpriced without the Advair approvals ' unfortunate about the 2019 target for Advair !!!
Geoff Laidlaw
Geoff Laidlaw May 08, 2018 11:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Almost got me money back !!!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Our Apps
DOWNLOAD APPApp store
Investing.com
© 2007-2022 Fusion Media Limited. All Rights Reserved.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
  • Sign up for FREE and get:
  • Real-Time Alerts
  • Advanced Portfolio Features
  • Personalized Charts
  • Fully-Synced App
Continue with Google
or
Sign up with Email